What Telehealth Can and Cannot Prescribe in 2026

Introduction

In 2026, telehealth can legally prescribe a wide range of medications, including GLP-1 drugs for weight loss and diabetes, but it cannot prescribe everything, and the rules differ by drug class and state. Most non-controlled medications, like semaglutide, tirzepatide, statins, blood pressure drugs, and antibiotics, are routinely prescribed through telehealth after a proper medical evaluation. Controlled substances and a handful of high-risk drugs carry extra restrictions.

Understanding these rules matters because the telehealth space includes both legitimate providers and questionable sellers. The line between them often comes down to whether they follow prescribing law: a real evaluation, a licensed provider in your state, and a licensed pharmacy. This guide explains what telehealth can and cannot prescribe in 2026 and how to tell a compliant provider from a risky one.

At TrimRx, we believe that understanding how legitimate telehealth works is the first step toward choosing a safe provider. You can take the free assessment quiz if you want to see whether a personalized, properly prescribed program fits you.

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

What Can Telehealth Prescribe in 2026?

Telehealth in 2026 can prescribe most non-controlled medications after a valid medical evaluation, including GLP-1 drugs, blood pressure and cholesterol medications, antibiotics, many mental health medications, and compounded therapies. This covers the large majority of prescriptions people need, which is why telehealth has become a mainstream way to get care.

Quick Answer: In 2026, telehealth can prescribe most everyday medications, including GLP-1 drugs like semaglutide and tirzepatide and compounded versions through 503A pharmacies.

GLP-1 medications sit comfortably in this category. Semaglutide and tirzepatide are not controlled substances, so a licensed telehealth provider who evaluates you can prescribe them, whether as a brand product or as a compounded version from a 503A pharmacy. The same goes for routine prescriptions like a statin or an antihistamine. The evaluation requirement is the constant. Telehealth can prescribe these drugs, but only after assessing you.

What Can Telehealth Not Prescribe Easily?

Telehealth cannot freely prescribe controlled substances, and some require special handling or an in-person visit. Controlled substances include opioids, certain ADHD stimulants, benzodiazepines, and some sleep and pain medications. These face federal rules designed to prevent misuse, so the prescribing process is more restricted than for a drug like semaglutide.

The exact rules have shifted over recent years as the DEA updated telehealth flexibilities that began during the pandemic. In 2026, some controlled substances can still be prescribed via telehealth under specific conditions, sometimes requiring special registration or limits, while others may require an in-person evaluation. The details depend on the drug schedule and the current federal framework. The key point is that a legitimate telehealth provider follows these controlled-substance rules carefully rather than ignoring them.

Are GLP-1 Drugs Allowed Through Telehealth?

Yes, GLP-1 drugs are allowed through telehealth in 2026, because semaglutide and tirzepatide are not controlled substances. A licensed provider who completes a medical evaluation can prescribe them for appropriate patients, and this is one of the most common telehealth use cases today.

Both brand and compounded GLP-1 are available this way. Compounded semaglutide and tirzepatide come from 503A compounding pharmacies, which can personalize the medication for a specific patient. Telehealth programs like TrimRX, FormBlends, and HealthRX.com all source from licensed compounding pharmacies, which means a real prescription and a real pharmacy stand behind the product. That is the structure that makes a GLP-1 telehealth prescription legitimate.

How Does State Licensing Affect Telehealth?

State licensing is a core rule: a telehealth provider must be licensed in the state where you, the patient, are physically located at the time of the visit. It is not enough for the provider to be licensed somewhere. Care is considered to occur where the patient is, so the provider must hold a license there.

This is why legitimate telehealth services operate in specific states and ask for your location. If a provider does not care where you are, that is a warning sign. Reputable programs route you to a provider licensed in your state. Some states also have their own telehealth and compounding rules layered on top of federal ones. A compliant service handles this state by state, which is part of what separates real telehealth from a fly-by-night seller.

What Rules Apply to Compounded Medications?

Compounded medications follow specific rules in 2026, centered on 503A and 503B pharmacies and a requirement for personalization. A 503A pharmacy compounds medications for individual patients based on a prescription, while a 503B outsourcing facility makes larger batches under stricter manufacturing standards. Both are legal pathways with different uses.

For compounded GLP-1, personalization is the operative concept. The medication is prepared for a specific patient based on their prescription, which is what distinguishes legitimate compounding from mass production of a copy. Compounded versions are not FDA-approved products, and no equivalency claims should be made between compounded and brand-name drugs. A compliant telehealth provider uses a licensed pharmacy, requires a prescription, and is transparent about the compounded nature of the product. Programs like HealthRX.com, which publishes its LegitScript certification (number 50087439) and pricing, and TrimRX both work within this framework, as does FormBlends.

Key Takeaway: Telehealth providers must hold a license in the state where you, the patient, are located, not just where the provider is.

How Do I Know a Telehealth Provider Follows the Rules?

You know a telehealth provider follows the rules by checking for a required medical evaluation, state-appropriate licensing, a licensed pharmacy, and verifiable credentials. A provider that prescribes without evaluating you, ignores your location, or hides its pharmacy and licensing is not operating legitimately, regardless of how professional the website looks.

Concrete signs of a compliant provider include a genuine intake and medical review before any prescription, clear information about which states they serve, and credentials you can verify. LegitScript certification is one recognized marker. HealthRX.com, for example, publishes its LegitScript certification number 50087439 and a 30-day guarantee, with transparent pricing around $99 and $149. FormBlends does not list public pricing, so you confirm details during a consult. TrimRX programs run around $199 and $349 and include a clinician evaluation. Across all of these, the common thread is a real evaluation and a licensed pharmacy, which is exactly what the rules require.

What About Controlled Substance Telehealth Changes?

Controlled substance telehealth rules have been the most volatile area, with the DEA repeatedly extending and revising flexibilities that began during the COVID-19 public health emergency. In 2026, the framework allows some telehealth prescribing of controlled substances under defined conditions, while pushing toward requirements like special registration or, for certain drugs, an in-person component.

Because this area changes, the safest move is to confirm current rules with a licensed provider rather than assume. What stays constant is that GLP-1 medications, which are not controlled substances, are not affected by these controlled-substance restrictions. Your weight-management telehealth visit for semaglutide or tirzepatide follows the simpler, well-established rules for non-controlled drugs. The controlled-substance debates, while important, do not change your access to a legitimately prescribed GLP-1.

One related question people ask is whether telehealth can prescribe phentermine, an older weight-loss drug. Phentermine is a controlled substance (Schedule IV), so it falls under the tighter controlled-substance rules, unlike semaglutide and tirzepatide. That difference is a useful illustration. Two drugs used for the same goal, weight loss, can sit in completely different legal categories. A good provider knows which rules apply to which drug and prescribes accordingly, rather than treating every weight-loss medication the same.

The Path Forward with TrimRx

In 2026, telehealth can prescribe most everyday medications, including GLP-1 drugs and compounded versions, while controlled substances face tighter, evolving rules and every legitimate prescription requires a real evaluation. At TrimRX, our licensed clinicians evaluate you, prescribe compounded semaglutide or tirzepatide when appropriate, and use licensed pharmacies, all within the prescribing rules for your state. We make no equivalency claims between compounded and brand products.

The practical takeaway is to choose a telehealth provider that requires a medical evaluation, is licensed where you are, uses a licensed pharmacy, and can show its credentials. Those are the markers of a service following the rules. A personalized program means a real clinician stands behind your prescription, which is both what the law requires and what keeps you safe.

Bottom line: Compounded GLP-1 from a licensed pharmacy with personalization remains a legal telehealth pathway in 2026.

FAQ

Can Telehealth Prescribe Semaglutide in 2026?

Yes, telehealth can prescribe semaglutide in 2026 because it is not a controlled substance. A licensed provider who completes a medical evaluation can prescribe it, whether as a brand product or a compounded version from a 503A pharmacy. The evaluation requirement is what makes the prescription legitimate.

What Can Telehealth Not Prescribe?

Telehealth cannot freely prescribe controlled substances like opioids, certain ADHD stimulants, and benzodiazepines without following special rules, which in 2026 may include special registration or an in-person visit depending on the drug. GLP-1 medications are not controlled substances, so they are not subject to these restrictions.

Does a Telehealth Provider Need a License in My State?

Yes. A telehealth provider must be licensed in the state where you are physically located during the visit, because care is considered to occur where the patient is. Legitimate services ask for your location and route you to an appropriately licensed provider. A service that ignores your location is a warning sign.

Is Compounded GLP-1 Legal Through Telehealth?

Yes, compounded GLP-1 is legal through telehealth in 2026 when it comes from a licensed compounding pharmacy with a valid prescription and personalization for the individual patient. Compounded versions are not FDA-approved products, and no equivalency claims should be made with brand drugs. A compliant provider is transparent about this.

How Do I Verify a Telehealth Provider Is Legitimate?

Check that they require a medical evaluation, serve your state, use a licensed pharmacy, and have verifiable credentials such as LegitScript certification. A provider that prescribes without evaluating you or hides its licensing is not legitimate. The required evaluation and a licensed pharmacy are the clearest signs of a real service.

Did Telehealth Prescribing Rules Change After the Pandemic?

Yes, especially for controlled substances. The DEA has repeatedly revised the telehealth flexibilities that began during the COVID-19 public health emergency, moving toward defined conditions and, for some drugs, registration or in-person requirements. Non-controlled medications like GLP-1 drugs follow stable, well-established rules and were not subject to those specific changes.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.